Valbiotis Shares Surge 5.66% at Midday After +46% Over Three Months
Valbiotis stock is experiencing a strong increase this Tuesday at midday, rising by 5.66% to €1.046. This acceleration is part of an upward trend that has been ongoing for several weeks, with the stock showing a gain of over 46% over three months. The Clermont-based biotech is evolving in a context of a generalized rebound in European markets.
Current Session Performance
During the session, Valbiotis is trading at €1.046, up from €0.99 at the close of the previous session, marking a 5.66% increase. Over the week, the stock has gained 7.28%, extending a significant recovery movement as the value has increased by more than 46% in three months. However, the performance over a year remains slightly negative at -2.89%, reflecting a still fragile stock path after previous declines. This rebound occurs as European markets show a clear improvement this Tuesday. The CAC 40 is up 2.16% in the session, at 8,086.64 points, while the German DAX has gained 2.22% and the London FTSE 100 has advanced by 1.67%. In Asia, the Nikkei 225 closed up 2.88% and the Hang Seng finished at +2.17%. This renewed appetite for risk assets benefits small-cap stocks like Valbiotis, whose low beta (0.13) usually indicates limited sensitivity to general market movements.
Technical Analysis
Technically, Valbiotis' stock price is now above its 50-day (€0.90) and 200-day (€0.83) moving averages, a positioning that reflects the strengthening of the medium-term bullish trend. The stock has crossed its 50-day moving average in recent weeks, a signal monitored by traders to validate a turnaround in dynamics. However, the 14-day RSI stands at 41, a still moderate level that indicates neither overbought nor oversold conditions, leaving room for progression before reaching alert zones. The stock is approaching the upper Bollinger band (€1.11) while remaining below the resistance threshold identified at €1.21. This level is the next technical zone to watch: crossing it would confirm the strength of the ongoing movement. The monthly volatility, at nearly 13%, remains high for this type of capitalization.
